Euphorbia lunulata (Euphorbiaceae) is found in the southeast of China. It has long been used as a traditional crude drug for the treatment of bronchial asthma and chronic bronchitis.
1) Previous investigations of the whole plants of E. lanulata have yielded kaempferol, quercetin, kaempferol 3-O-Lrhamnoside, quercetin 3-O-L-rhamnoside, 6,7-dihydroxycoumarin and maoyancaosu. 2, 3) More than 30 types of cytokines and growth factors have been identified as ligands to date. 4) Recently, those genes were cloned one after another, yielding recombinant genes. However, only very few of the peptides and proteins made in this way are used as drugs. The reasons such peptides are hard to utilize as medicines are: metabolization, absorption, neutralization antibody, side effects, etc. Screening of low molecular compounds mimicking a ligand of protein is carried out to solve these problems. However, conventional screening methods derive from ligand competent cells and require tracking of the signal after ligands bind to receptors, but signal detection is not easy.
We earlier developed a high-throughput, cell proliferationbased screening assay using the human granulocyte colony stimulating factor (G-CSF)-, erythropoietin (EPO)-, thrombopoietin (TPO)-, interleukin-10 (IL-10)-and insulin-dependent cell lines (BAF/GCSFR, BAF/EPOR, BAF/TPOR, BAF/IL10R and BAF/InsR) to identify low molecular compounds that mimic human ligands. 5) These cell lines were originally derived from a mouse interleukin-3 (mIL-3)-dependent cell line, BAF/B03. The BAF/GCSFR, BAF/EPOR, BAF/TPOR, BAF/IL10R and BAF/InsR cells proliferate in response to the corresponding ligand or rmIL-3, and undergo apoptosis when deprived of these growth factors.
In the present study, we searched for compounds that mimic human ligands by using this screening method jointly with a process for purification of EL extract.
We discovered that EL showed proliferation activity for BAF/InsR and BAF/IL10R. Therefore, analysis of EL was undertaken to identify the active compounds. Here we describe the isolation and structure elucidation of one new flavonoid galactoside, quercetin 3-O-(2Љ,3Љ-digalloyl)-b-Dgalactopyranoside (1), and four known ones, quercetin 3-O- (4) , and gallic acid (5) as well as their ligand-like activities.
Results and Discussion
Cell proliferation activities for BAF/InsR and BAF/IL10R after stimulation with EL extract, fractions or isolated compounds are shown in Table 1. EL showed proliferation activity for BAF/InsR (22.9 mU/ ml-corresponding quantity of human recombinant preparation, the following is the same, 30 mg/ml) and BAF/IL10R (0.218 mU/ml, 30 mg/ml). On the other hand, there was no proliferation activity for BAF/GCSFR, BAF/EPOR or BAF/ TPOR. EL was partitioned with chloroform, ethyl acetate, n-butanol, and water-soluble fraction, successively. Ethyl acetate fraction showed both BAF/InsR (20.6 mU/ml, 30 mg/ ml) and BAF/IL10R (0.247 mU/ml, 30 mg/ml) proliferation activities. Therefore, we have focused our efforts on researching the chemical constituents of the ethyl acetate soluble fraction. The ethyl acetate soluble fraction was then separated by Sephadex LH-20 column chromatography to yield 9 fractions. Fractions 5 and 6 showed strong proliferation activities for BAF/InsR; Fractions 3, 4 and 8 showed comparatively strong proliferation activities for BAF/IL10R. Compounds 1, 2 and 4 were isolated from fraction 6, compound 3 was isolated from fraction 4, and compound 5 was isolated from fraction 3.
Compound 1 was obtained as a yellow amorphous powder and was positive in the Mg-HCl test. The molecular structure of 1 was established as C 35 In our investigation of a cell proliferation-based screening assay using human ligand-dependent cell lines for medicinal herbal extracts, the acetone extract of the whole plants of Euphorbia lunulata (EL) was observed for its proliferation activity for insulin-and interleukin-10 ( (Table 2) . These data coupled with the FAB-MS data indicated that 1 may be a digallate of quercetin galactoside. Quercetin, gallic acid, and D-galactose were identified by hydrolysis of 1 (see Experimental). Furthermore, comparison of the carbon shifts of the aglycone with those of published data for quercetin revealed an upfield shift of C-3 (Dd 3.0 ppm) and a downfield shift of C-4 (Dd 1.1 ppm) indicating the placement of the sugar residue at C-3. 8) HMBC spectral analysis supported further evidence for this assignment. The galloyloxy groups in 1 were linked at C-2 and C-3 of the galactose residue based on the remarkable downfield shifts of H-2Љ (d 5.63, dd, Jϭ10.2, 7.8 Hz), and H-3Љ (d 5.14, dd, Jϭ10.2, 3.1 Hz) signals. The HMBC NMR spectrum of 1 indicated the carbon signal (d 165.2, 164.9) of the two galloyl carbonyl units showed correlations with the H-2Љ and H-3Љ signals, respectively. These data confirmed that the galloyloxy groups were linked at C-2 and C-3 of galactose moiety. On the basis of the forgoing observations, 1 was assigned as quercetin 3 
Compounds 2, 3, 4, and 5 are known compounds whose structures were elucidated by their spectral data and comparison with reports in the literature. 7, 9, 10) Compounds 1 and 2 showed proliferation activity for BAF/InsR. Stimulation with 1 or 2 was dose-dependent and The proliferative activity for BAF/IL10R was observed in 1, 2, 4 and 5, although the activity of 1 and 2 was weaker than that of 4 and 5. Stimulation with those four compounds was dose-dependent and maximal at 30 mg/ml. IL-10-like activity of 1 and 2 may derive from a skeleton of 4 and 5.
Zhang et al. found a nonpeptidyl small molecule insulin mimetic from a fungal metabolite. 11) Its structure was a benzoquinone derivative that binds two indolyl groups. In the meantime, the small molecular compounds (1, 2) that mimic insulin that we got from a higher plant were queretin 3-Ogalactoside bound to galloyl group at the galactosyl moiety. There was no activity in 4, 5, or 3, which do not bind to the galloyl group. Compounds 1 and 2 will become the seed compounds for the development of a nonpeptidyl insulin substitutional medicine.
IL-10 is an anti-inflammatory cytokine that may be important in regulating the asthmatic inflammatory response. 12, 13) Therefore, The IL-10-like activity found in 4 and 5 is felt to support the pharmacological use of EL. This is the first report of discovery of insulin mimic compounds and IL-10 mimic compounds from a higher plant. At the same time it was shown that our new cell proliferation-based screening method was useful for a ligand search in natural products.
Experimental
General Procedures The UV spectrum was obtained in MeOH on a Shimadzu UV-160 spectrophotometer, and the IR spectrum was recorded on a JASCO FT/IR 300E spectrophotometer. Optical rotations were measured in MeOH on a JASCO DIP-360 polarimeter. The NMR spectra were recorded on a JEOL JNM-LA400 spectrometer, with TMS as an internal standard. The MS were obtained on a JEOL JMS GCmate spectrometer. Extraction and Isolation The whole plants of E. lunulata (2.3 kg) were extracted twice with 70% acetone. Evaporation of the solvent under reduced pressure from the combined extract made the 70% acetone extract 675 g. The extract was dissolved and suspended in water (2 l) and partitioned with chloroform (3ϫ2 l), ethyl acetate (3ϫ2 l), and n-butanol (3ϫ2 l). The amounts extracted were 65.2, 52.4, and 86.5 g, respectively, and the residual aqueous extract yielded 450.1 g.
The ethyl acetate fraction was subjected to Sephadex LH-20 column chromatography (6.5ϫ35 cm, eluted with MeOH : H 2 O 50 : 50→100 : 0). The column chromatographic fractions (200 ml each) were combined according to TLC monitoring into nine fractions. Fraction 6 was subjected to CHP-20 column chromatography (3ϫ20 cm, eluted with MeOH : H 2 Oϭ40 : 60). The column chromatographic fractions (100 ml each) were combined according to TLC monitoring into nine portions. Portion eight yielded a yellow solid 4 (354 mg). Portion four was isolated and further purified by HPLC (YMC Guard pack ODS Al, 10ϫ150 mm, MeOH : H 2 O, 4 : 6) to yield 1 (21 mg). Portion five was isolated and further purified by HPLC (YMC Guard pack ODS Al, 10ϫ150 mm, MeOH : H 2 O, 4 : 6) to yield 2 (210 mg). Fraction four yielded a yellow solid 3 (7.8 mg Acid Hydrosis of 1 Compound 1 (10 mg) was dissolved in 10% H 2 SO 4 and heated at 85°C for 3 h. After cooling, the reaction mixture was neutralized by passage though an Amberlite IRA-93ZU (Organo) column and then partitioned between ethyl acetate and water. The ethyl acetate layer was concentrated and the concentrate was pass through an ODS C-18 column, successively eluted with 20% MeOH and 60% MeOH. Hematopoietic Growth Factor and Reagents Recombinant human G-CSF (rhG-CSF), recombinant human erythropoietin (rhEPO), recombinant human thrombopoietin (rhTPO), and recombinant human IL-10 (rhIL-10) were purchased from R&D Systems (Minneapolis, MN, U.S.A.). Recombinant human insulin (rhIns, NovalinR, Novo Nordisk, Bagsvaerd, Denmark) was purchased from Novo Nordisk.
Plasmids Construction of the expression plasmids, which include human G-CSF receptor (GCSFR), EPO receptor (EPOR), TPO receptor (TPOR), and IL-10 receptor (IL-10R), were described in detail previously. 5) Insulin receptor (InsR) cDNA was amplified from Quick-clone (human spleen, Clontech, Palo Alto, CA, U.S.A.) by PCR. The primer pairs used were: InsR forward 1, 5Ј-ACCGGGAGCGCGCGCTCTGA-3Ј, InsR reverse 1, 5Ј-GATTGGATCCAGGGGCACAGA-3Ј, InsR forward 2, 5Ј-TGGATC-CAATCTCAGTGTCTAAC-3Ј and InsR reverse 2, 5Ј-TTAGGAAGGATTG-GACCGAGGCA-3Ј. Amplification was performed with a Perkin Elmer DNA Cycler 9600 (PE Applied Biosystems, Foster City, CA, U.S.A.); it involved 30 cycles of denaturation at 94°C for 15 s, and annealing and extension at 68°C for 4 min. The PCR products were cloned into vector pCR2.1 (Invitrogen, Carlsbad, CA, U.S.A.), and the nucleotide sequences of the inserts were determined. PCR products were ligated, and digested with NcoI and SalI followed by treatment with Klenow enzyme (Takara Shuzo Co., Ltd., Kyoto, Japan) to give blunt ends. The multiple cloning site of pIRESpuro (BD Biosciences Clontech, Palo Alto, CA, U.S.A.) was expanded by digestion with EcoRI (blunt-ended with Klenow enzyme). Then the fulllength of InsR cDNA was ligated into this position of pIRESpuro, generating pIRESpuro-InsR.
Transfection and Cell Culture The mouse pro-B cell line, BAF/B03, was culutred as previously detailed. 5) pIRESpuro-InsR was electroporated with a GenePulser apparatus (Bio-Rad, Hercules, CA, U.S.A.) with a 250-V pulse at 960 mF. The clone resistant to puromycin (2 mg/ml) (Sigma) was selected by limiting dilution in Dulbecco's modified Eagle's medium (DMEM; Sigma, St. Louis, MO, U.S.A.) supplemented with 10% fetal bovine serum (FBS) and rhIns (1 U/ml). The stably transfected cell line obtained is referred to as BAF/InsR.
Proliferation Assay Stably transfected cells were cultured as previously detailed. and 1-methoxy-5-methylphenazinium methylsulfate (1-methoxy PMS) (2ϫ10 Ϫ4 M) as substrate, and cultured for 3 h at 37°C in a humidified atmosphere of 5% CO 2 in air. Optical density was measured at 450 nm using a microplate reader (CORONA, Hitachi, Japan).
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